Rosetta Genomics Prices IPO

Rosetta Genomics Ltd., an Israel-based drug company focused on microRNAs, priced 3.75 million ordinary shares at $7 per share, for an IPO take of approximately $26.25 million. It originally filed to sell three million shares at $11-$13 per share, but later amended the terms to 4.75 million shares being offered at $7.50-$8.50 per share. It will trade on the Nasdaq under ticker symbol ROSG, while C.E. Unterberg Towbin served as lead underwriter. Backers include Insight Capital and Kadima Hi-Tech Ltd.< ?xml:namespace prefix = o ns = "urn:schemas-microsoft-com:office:office" />